ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1208

Cholesterol Loading Induces Neutrophil Extracellular Traps, and Atorvastatin Attenuates This Effect

Ming-Lin Liu1,2, Muhammad Bashir1,3, Kevin Williams4 and Victoria Werth5,6, 1Department of Dermatology, University of Pennsylvania, Philadelphia, PA, 2Department of Dermatology,, Philadelphia V.A. Hospital, Philadelphia, PA, 3Department of Dermatology, Philadelphia V.A. Hospital, Philadelphia, PA, 4Department of Medicine, Temple University School of Medicine, Philadelphia, PA, 5Dermatology, University of Pennsylvania, Philadelphia, PA, 6Dermatology, Philadelphia V.A. Hospital, Philadelphia, PA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: cholesterol and statins, Neutrophil Extracellular Traps

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease: Signaling Mechanisms

Session Type: Abstract Submissions (ACR)

Background/Purpose

Neutrophils are the most common white blood cell, but their role in autoimmune and cardiovascular diseases has been underestimated. As part of host defense, neutrophils release granule proteins and chromatin DNA into the extracellular space to form neutrophil extracellular traps (NETs). Recent studies reported the presence of NETs in atherosclerotic lesions, and NETs promote thrombosis. Moreover, pharmacological inhibition of NET formation through peptidyl-arginine deiminase blockade can reduce atherosclerosis and arterial thrombosis in mice. Hypercholesterolemia is the underlying cause of atherosclerotic cardiovascular disease. Nevertheless, the effects of cholesterol loading on NET formation and the relevant cellular mechanisms have not been investigated.

Methods

Primary neutrophils were isolated from healthy donors by sequential centrifugation with Histopaque 1077 and 1119. Cultured human HL-60 cells were differentiated into neutrophil-like cells with 1.2% DMSO. Cholesterol was delivered to primary and HL-60 neutrophils as a water-soluble complex with meythl-β-cyclodextrin (MCD, Chol/MCD), which is widely used to modify the cholesterol content of cultured cells without potentially confounding effects from receptor engagement. Cells were fixed and then stained with Sytox Green, which indicates exposed nucleic acids. Formation of NETs was assessed with a fluorescence microplate reader and by fluorescence microscopy. To study the effects of atorvastatin on NET formation, selected plates were pretreated with this agent before exposure to Chol/MCD. 

Results

We found that Chol/MCD loading could induce NET formation in a time- and dose-dependent manner in primary neutrophils [4491±60 RFUs (relative fluorescent units) for control without Chol/MCD, 6553±206 RFUs with 12.5 µg/ml Chol/MCD, and 9297±223 RFUs with 25 µg/ml Chol/MCD, mean±SEM, P<0.001 by ANOVA], and in HL-60 neutrophils, detected with a fluorescence microplate reader. Both findings were confirmed by examination of the NET structure with fluorescent microscopy. Importantly, pretreatment of neutrophils with low or lower dose (10 or 25 µM), but not high dose (75 µM), atorvastatin, significantly attenuated cholesterol-induced NETosis in vitro. 

Conclusion

Our studies indicated that cholesterol loading can induce neutrophil extracellular trap formation in vitro. Low-dose atorvastatin can attenuate cholesterol-induced NETosis. Our preliminary results indicate a potential role of hypercholesterolemia in NET formation and a potential beneficial role for statins.


Disclosure:

M. L. Liu,
None;

M. Bashir,
None;

K. Williams,
None;

V. Werth,

Amgen,

9.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cholesterol-loading-induces-neutrophil-extracellular-traps-and-atorvastatin-attenuates-this-effect/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology